title: Clinical trials in patients with biochemically relapsed prostate cancer.
abstract: In this section there is a wide diversity of mini-reviews, covering several areas of interest for readers. Authors from the USA write about clinical trials in patients with biochemically relapsed prostate cancer, again bridging the divide between medical oncologists and urologists who specialise in urological oncological surgery. The second paper is a joint one from Germany and the USA, bringing the reader up to date with advances in the treatment of stress urinary incontinence. Finally there are two papers from Australia describing the use of positron emission tomography in renal cancer and in prostate cancer.
authors.affiliation: UCSF Comprehensive Cancer Center, University of California/San Francisco, San Francisco, CA 94115, USA.
authors.forename: Amy M
authors.initials: AM
authors.lastname: Lin
authors.forename: Brian I
authors.initials: BI
authors.lastname: Rini
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Small
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000097:blood*; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000473:pathology; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D017430:Prostate-Specific Antigen